tirzepatide to semaglutide vs. for Weight Loss Switching between weight-loss medications -

Thyroxine revisited

Employers now report GLP-1s among their highest pharmacy expenses

Across longitudinal cohorts, the menopause transition is accompanied by rises in total cholesterol, LDL, and by adverse shifts in HDL quantity and functionchanges that amplify atherogenic and hepatic inflammatory signaling 125,126,127,128,129,130

Research on GLP-1 use in post-bariatric patients is still emerging, but preliminary data suggests injectable semaglutide can be effective when patients have completed their surgical recovery phase

The definitions of excellent or good in the pediatric clinical trial were unchanged as compared to the previously conducted prophylaxis clinical trial in adolescent and adult patients